Intrinsic Value of S&P & Nasdaq Contact Us

CERo Therapeutics Holdings, Inc. CERO OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
13/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — CERO

CERo Therapeutics Holdings, Inc. (CERO) has a market capitalization of $38.57K and trades at $0.03. The 52-week range is 0.03-28.4.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-18.15.

The stock has a beta of 0.24, operates in the Healthcare sector.

Trading Data
Current Price$0.03
52-Week Range0.03-28.4
Volume479.38K
Avg Volume (30D)474.24K
Market Cap$38.57K
Beta (1Y)0.24
Company
IPO Date2021-11-30
Employees8
CEOChristopher Ehrlich
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS71902K4022
CUSIP71902K402
Income (Latest Year)
EBITDA$-6.57M
Operating Income$-15.3M
Net Income$-7.73M
EPS$-18.15
EPS Diluted$-18.15
Shares Outstanding$579.43K
Balance Sheet (Latest Year)
Total Assets$6.21M
Current Assets$3.71M
Cash & ST Investments$3.33M
Total Liabilities$8.1M
Total Debt$1.58M
Net Debt$-1.75M
Total Equity$-1.89M
Debt / Equity-0.83
Valuation Ratios
P/E Ratio-0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message